Display options
Cite
Kim J, Chung JY, Hwang JR, et al. Identification of Candidate Genes Associated with Susceptibility to Ovarian Clear Cell Adenocarcinoma Using . J Clin Med. 2020;9(4)doi: 10.3390/jcm9041137.
Kim, J., Chung, J. Y., Hwang, J. R., Lee, Y. Y., Kim, T. J., Lee, J. W., Kim, B. G., Bae, D. S., Choi, C. H., & Hewitt, S. M. (2020). Identification of Candidate Genes Associated with Susceptibility to Ovarian Clear Cell Adenocarcinoma Using . Journal of clinical medicine, 9(4), . https://doi.org/10.3390/jcm9041137
Kim, Jihye, et al. "Identification of Candidate Genes Associated with Susceptibility to Ovarian Clear Cell Adenocarcinoma Using ." Journal of clinical medicine vol. 9,4 (2020). doi: https://doi.org/10.3390/jcm9041137
Kim J, Chung JY, Hwang JR, Lee YY, Kim TJ, Lee JW, Kim BG, Bae DS, Choi CH, Hewitt SM. Identification of Candidate Genes Associated with Susceptibility to Ovarian Clear Cell Adenocarcinoma Using . J Clin Med. 2020 Apr 16;9(4). doi: 10.3390/jcm9041137. PMID: 32316112; PMCID: PMC7231141.
Copy Download .nbib Format: NLM
Share it on

J Clin Med. 2020 Apr 16;9(4). doi: 10.3390/jcm9041137.

Identification of Candidate Genes Associated with Susceptibility to Ovarian Clear Cell Adenocarcinoma Using .

Journal of clinical medicine

Jihye Kim, Joon-Yong Chung, Jae Ryoung Hwang, Yoo-Young Lee, Tae-Joong Kim, Jeong-Won Lee, Byoung-Gie Kim, Duk-Soo Bae, Chel Hun Choi, Stephen M Hewitt

Affiliations

  1. Department of Obstetrics and Gynecology, Dankook University Hospital, Cheonan 31116, Korea.
  2. Experimental Pathology Laboratory, Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
  3. Samsung Biomedical Research Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Korea.
  4. Departments of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Korea.

PMID: 32316112 PMCID: PMC7231141 DOI: 10.3390/jcm9041137

Abstract

Ovarian clear cell adenocarcinoma (Ov-CCA) has a higher prevalence in the Japanese ancestry than other populations. The ancestral disparities in Ov-CCA prevalence suggests the presence of Ov-CCA-specific genetic alterations and may provide an opportunity to identify the novel genes associated with Ov-CCA tumorigenesis. Using 94 previously reported genes as the phenotypic trait, we conducted multistep expression quantitative trait loci (eQTL) analysis with the HapMap3 project datasets. Four single-nucleotide polymorphisms (SNPs) (rs4873815, rs12976454, rs11136002, and rs13259097) that had different allele frequencies in the Japanese ancestry and seven genes associated in

Keywords: ancestry; clear cell adenocarcinoma; epithelial ovarian cancer; quantitative trait loci; single-nucleotide polymorphism

References

  1. J Med Virol. 2016 Mar;88(3):474-80 - PubMed
  2. Nat Biotechnol. 2012 Nov;30(11):1095-106 - PubMed
  3. N Engl J Med. 2010 Jul 8;363(2):166-76 - PubMed
  4. Int J Obes (Lond). 2019 Dec;43(12):2480-2490 - PubMed
  5. PLoS Genet. 2020 Feb 14;16(2):e1008641 - PubMed
  6. Gynecol Oncol. 2002 Mar;84(3):399-403 - PubMed
  7. PLoS One. 2014 Aug 18;9(8):e105393 - PubMed
  8. Nat Genet. 2015 Aug;47(8):888-97 - PubMed
  9. Bioinformatics. 2010 Oct 1;26(19):2474-6 - PubMed
  10. Int J Gynaecol Obstet. 2006 Nov;95 Suppl 1:S161-92 - PubMed
  11. Biomed Res Int. 2014;2014:934261 - PubMed
  12. Oncogene. 2001 Jan 18;20(3):399-403 - PubMed
  13. Genes Chromosomes Cancer. 1992 Jan;4(1):16-24 - PubMed
  14. Cell. 2013 Jan 31;152(3):633-41 - PubMed
  15. Genome Biol. 2016 Jun 06;17(1):122 - PubMed
  16. Cancer Invest. 2013 Nov;31(9):607-15 - PubMed
  17. Cancer Res. 1992 Oct 1;52(19):5368-72 - PubMed
  18. Mol Endocrinol. 2010 Sep;24(9):1872-85 - PubMed
  19. BMC Bioinformatics. 2012 Dec 24;13:335 - PubMed
  20. Mol Genet Genomics. 2016 Jun;291(3):1035-51 - PubMed
  21. Bioinformatics. 2017 Feb 15;33(4):471-474 - PubMed
  22. Gynecol Oncol. 2019 May;153(2):343-355 - PubMed
  23. Cancer Lett. 2005 Jul 8;225(1):121-30 - PubMed
  24. Cancer Epidemiol Biomarkers Prev. 2015 Nov;24(11):1731-8 - PubMed
  25. BMC Bioinformatics. 2018 Oct 12;19(1):373 - PubMed
  26. Gynecol Oncol. 2011 May 1;121(2):407-15 - PubMed
  27. J Cancer Res Clin Oncol. 2010 May;136(5):685-94 - PubMed
  28. Cancer Discov. 2013 Jun;3(6):636-47 - PubMed
  29. Proc Natl Acad Sci U S A. 2017 May 30;114(22):E4416-E4424 - PubMed
  30. Cancer Res. 2017 Jul 15;77(14):3857-3869 - PubMed
  31. Philos Trans R Soc Lond B Biol Sci. 2013 May 06;368(1620):20120362 - PubMed
  32. Nature. 2015 Oct 1;526(7571):68-74 - PubMed
  33. Br J Cancer. 2012 Jun 26;107(1):91-9 - PubMed
  34. Nat Genet. 2011 Jun;43(6):513-8 - PubMed
  35. Cancer Genet. 2013 May;206(5):145-53 - PubMed
  36. Nat Commun. 2015 Sep 22;6:8234 - PubMed
  37. Cell Death Differ. 2016 Jan;23(1):64-75 - PubMed
  38. Mol Carcinog. 2010 Mar;49(3):283-9 - PubMed
  39. CA Cancer J Clin. 2015 Mar;65(2):87-108 - PubMed
  40. PLoS Genet. 2010 Nov 11;6(11):e1001204 - PubMed
  41. Prostate. 2008 Feb 15;68(3):264-8 - PubMed
  42. Hum Mol Genet. 2014 Oct 1;23(19):5294-302 - PubMed
  43. J Exp Clin Cancer Res. 2014 Jan 06;33:3 - PubMed
  44. J Pathol. 2018 Apr;244(5):550-564 - PubMed

Publication Types